Actively Recruiting
Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I
Led by Hospital Universitari Vall d'Hebron Research Institute · Updated on 2024-10-28
108
Participants Needed
1
Research Sites
44 weeks
Total Duration
On this page
Sponsors
H
Hospital Universitari Vall d'Hebron Research Institute
Lead Sponsor
I
Instituto de Salud Carlos III
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to identify differential traits in spontaneous migraine attacks that can help us predict the response to treatment with sumatriptan. Participants will be asked to register the headache characteristics before and after taking sumatriptan and whether the treatment was effective or not during four migraine attacks.
CONDITIONS
Official Title
Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Migraine with or without aura diagnosis according to ICHD-3 criteria
- Fewer than 8 migraine days per month
- Ability to read, write, and understand instructions
- Access to the internet and an email address
- Signed informed consent form
You will not qualify if you...
- Current preventive treatment for migraine
- Use of medication affecting the central nervous system
- Serious physical or psychiatric conditions
- Cardiovascular or liver disease
- Pregnancy or breastfeeding
- Any contraindication to triptans
- History of severe migraine attacks without response to triptans or NSAIDs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Actively Recruiting
Research Team
M
Marta Torres-Ferrús, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here